Suchergebnisse - "Pellegrino, Christine"

PubPharm (24)

1

A Case of Cholecystitis Camouflaging Cholangiocarcinoma

enthalten in: Cureus | 2024

von Paranji, S. | Vegunta, R. | Pellegrino, C.

2

A primary care learning collaborative to improve office systems and clinical management of pediatric asthma

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2021

von Weinberger, S. | Cowan, K. | Robinson, K. | +5

3

Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer

enthalten in: Clinical breast cancer | 2018

von Anampa, J. | Chen, A. | Wright, J. | +5

4

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer : a trial of the ECOG-ACRIN Cancer Research Group (E1104)

enthalten in: Breast cancer research and treatment | 2017

von Goldstein, L. | Zhao, F. | Wang, M. | +9

5

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)

enthalten in: Breast cancer research and treatment | 2017

von Goldstein, L. | Zhao, F. | Wang, M. | +9

6

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)

enthalten in: Breast cancer research and treatment | 2017

von Goldstein, L. | Zhao, F. | Wang, M. | +9

7

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)

enthalten in: Breast cancer research and treatment | 2017

von Goldstein, L. | Zhao, F. | Wang, M. | +9

8

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

9

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

10

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13